Precision BioSciences
DTIL
47 hedge funds and large institutions have $30.8M invested in Precision BioSciences in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
9% more funds holding
Funds holding: 43 → 47 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.61% less ownership
Funds ownership: 48.23% → 45.62% (-2.6%)
28% less capital invested
Capital invested by funds: $42.8M → $30.8M (-$12.1M)
29% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$708K |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$398K |
| 3 |
BlackRock
New York
|
+$312K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$201K |
| 5 |
Goldman Sachs
New York
|
+$186K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$867K |
| 2 |
PA
Perceptive Advisors
New York
|
-$638K |
| 3 |
Renaissance Technologies
New York
|
-$194K |
| 4 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
-$154K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$137K |
DTIL Hedge Fund Activity: Q2 2024 in Review
47 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q2 2024, worth a combined $30.8M — down 28% from $42.8M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new DTIL positions and 4 closed out — a net gain of 4 holders — while 10 added to existing stakes and 14 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $708K. The largest seller was Alyeska Investment Group, cutting an estimated $867K.
- 47 institutional investors held Precision BioSciences (DTIL) as of Q2 2024, up from 43 in Q1 2024.
- Funds reported $30.8M of Precision BioSciences stock for Q2 2024, down 28% quarter-over-quarter.
- 8 funds opened new Precision BioSciences positions in Q2 2024 and 4 closed out, a net change of +4 holders.
- The largest Precision BioSciences buyer in Q2 2024 was Janus Henderson Group, an estimated $708K added.
- The largest Precision BioSciences seller in Q2 2024 was Alyeska Investment Group, an estimated $867K sold.
Based on aggregated 13F filings for Q2 2024.